21 results on '"BOGUNIEWICZ, Mark"'
Search Results
2. 53863 Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 clinical trials of adults and children with atopic dermatitis.
3. 53713 Dupilumab Treatment Provides Long-Term Disease Control in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis Over 1 Year.
4. 26887 Effect of ruxolitinib cream on sleep disturbance and sleep impairment: Pooled analysis from two randomized phase 3 studies
5. 27406 Dupilumab improves signs and symptoms of severe atopic dermatitis in children aged 6–11 years with and without comorbid asthma
6. 27050 Efficacy of baricitinib 2-mg stratified by baseline body surface area in adults with moderate-to-severe atopic dermatitis
7. 43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization
8. 42314 Dupilumab Inhibits Vascular Leakage of Blood Proteins into the Skin and Improves Clinical Outcomes of Patients With Moderate to Severe Atopic Dermatitis
9. 42008 Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
10. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
11. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis
12. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP nonsteroidal cream in the management of mild to moderate atopic dermatitis in infants and children: P705
13. A multicenter randomized, vehicle-controlled, double-blind clinical study to examine the safety and efficacy of MAS063DP in the management of AD: P818
14. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis
15. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis
16. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
17. Cost of atopic dermatitis and eczema in the United States
18. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
19. Treatment, resources, and impact of atopic dermatitis-the triad study
20. Tacrolimus ointment 0.03 is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric and adult patients
21. Recombinant interferon gamma therapy for atopic dermatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.